Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
NB2013-HR German (GPOH) / Dutch (DCOG) Trial
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
|5||Not yet recruiting||
Phase I Study of Investigational Medicinal Products in Children With Relapsed/Refractory Neuroblastoma
† Study has passed its completion date and status has not been verified in more than two years.